Eli Lilly lowers guidance for 2021
![Photo: Mike Blake/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12933503.ece/ALTERNATES/schema-16_9/20210310-125910-5-1920x1920we-go.jpg)
US pharmaceutical company Eli Lilly lowers its upper estimate for this year's income in connection with the publication of its quarterly report on Tuesday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Analysts lose confidence in Biogen Alzheimer's approval
For subscribers
Eli Lilly has to wait a while longer for FDA verdict
For subscribers